RhumbLine Advisers’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-53,509
Closed -$2.02M 3208
2021
Q1
$2.02M Sell
53,509
-803
-1% -$30.3K ﹤0.01% 1909
2020
Q4
$924K Buy
54,312
+9,853
+22% +$168K ﹤0.01% 2169
2020
Q3
$209K Sell
44,459
-7,071
-14% -$33.2K ﹤0.01% 2672
2020
Q2
$314K Sell
51,530
-7,875
-13% -$48K ﹤0.01% 2557
2020
Q1
$135K Buy
59,405
+1,972
+3% +$4.48K ﹤0.01% 2708
2019
Q4
$264K Buy
57,433
+243
+0.4% +$1.12K ﹤0.01% 2652
2019
Q3
$222K Buy
57,190
+4,657
+9% +$18.1K ﹤0.01% 2712
2019
Q2
$317K Buy
52,533
+4,189
+9% +$25.3K ﹤0.01% 2584
2019
Q1
$648K Sell
48,344
-296
-0.6% -$3.97K ﹤0.01% 2212
2018
Q4
$452K Buy
48,640
+14,412
+42% +$134K ﹤0.01% 2341
2018
Q3
$476K Buy
34,228
+446
+1% +$6.2K ﹤0.01% 2296
2018
Q2
$534K Buy
33,782
+1,415
+4% +$22.4K ﹤0.01% 2280
2018
Q1
$556K Buy
32,367
+2,875
+10% +$49.4K ﹤0.01% 2172
2017
Q4
$646K Sell
29,492
-5,180
-15% -$113K ﹤0.01% 2135
2017
Q3
$1.42M Buy
34,672
+390
+1% +$16K ﹤0.01% 1809
2017
Q2
$1.03M Buy
34,282
+484
+1% +$14.6K ﹤0.01% 1941
2017
Q1
$1.22M Buy
33,798
+970
+3% +$35.1K ﹤0.01% 1823
2016
Q4
$1.65M Buy
32,828
+338
+1% +$16.9K ﹤0.01% 1565
2016
Q3
$1.71M Buy
32,490
+915
+3% +$48K ﹤0.01% 1517
2016
Q2
$1.31M Buy
31,575
+8,676
+38% +$359K ﹤0.01% 1620
2016
Q1
$930K Buy
22,899
+1,040
+5% +$42.2K ﹤0.01% 1837
2015
Q4
$907K Buy
21,859
+2,600
+14% +$108K ﹤0.01% 1874
2015
Q3
$296K Buy
19,259
+719
+4% +$11.1K ﹤0.01% 2550
2015
Q2
$461K Sell
18,540
-115
-0.6% -$2.86K ﹤0.01% 2387
2015
Q1
$426K Buy
18,655
+4,650
+33% +$106K ﹤0.01% 2390
2014
Q4
$378K Buy
14,005
+1,185
+9% +$32K ﹤0.01% 2445
2014
Q3
$150K Hold
12,820
﹤0.01% 2853
2014
Q2
$199K Buy
+12,820
New +$199K ﹤0.01% 2843